Hjem › Immunforsvar og lidelser › Pennsylvania › Philadelphia
Kliniske studier for Immunforsvar og lidelser i Philadelphia, PA
10 studier for Immunforsvar og lidelser søker deltakere på steder i og rundt Philadelphia (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
RekruttererObservasjonsstudie
- Philadelphia Veterans Administration Medical Center, Philadelphia
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi unna
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mi unna
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RekruttererFase 1
- University of Pennsylvania - Abramson Cancer Center, Philadelphia
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RekruttererFase 3
- Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program, Philadelphia
- Lewis Katz School of Medicine at Temple University, Philadelphia
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RekruttererFase 3
- Perelman Center for Advanced Medicine (PCAM) Hospital of The University of Pennsylvania Penn Blood Disorders Program, Philadelphia
- Lewis Katz School of Medicine at Temple University, Philadelphia
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RekruttererFase 1/2
- Thomas Jefferson University, Philadelphia
Abatacept for the Treatment of Giant Cell Arteritis
RekruttererFase 3
- University of Pennsylvania, Philadelphia
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
RekruttererFase 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
RekruttererFase 2
- Children's Hospital of Philadelphia, Philadelphia
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
RekruttererFase 1/2
- Nemours Children's Health, Wilmington · 25 mi unna
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
RekruttererFase 1/2
- University of Pennsylvania, Philadelphia
Immunforsvar og lidelser-studier i andre byer
- Washington, DC13 studier
- New York City, NY12 studier
- Boston, MA10 studier
- Atlanta, GA9 studier
- Portland, OR9 studier
- Houston, TX9 studier
- Los Angeles, CA8 studier
- Cleveland, OH8 studier
- Chicago, IL8 studier
- Milwaukee, WI6 studier
- Seattle, WA6 studier
- Cedar Rapids, IA6 studier
Andre studier i Philadelphia
- Kreft (alle typer)59 studier
- Brystkreft56 studier
- Ikke-småcellet lungekreft51 studier
- Metastatisk kreft46 studier
- Prostatakreft44 studier
- Kolorektal kreft44 studier
- Eggstokkreft44 studier
- Lungekreft36 studier
- Akut myelogen leukemi34 studier
- Hjertesvikt31 studier
- Endometriekreft28 studier
- Depresjon26 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.